ANDA 87902, held by Sun Pharma Canada. Triamcinolone Acetonide.
As of Nov 15, 2026, ANDA 87902 (Triamcinolone Acetonide), held by Sun Pharma Canada, was first approved by FDA on Dec 27, 1982, with 19 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 27, 1982 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Triamcinolone Acetonide0.1% ยท ointment;topical | Triamcinolone Acetonide | Discontinued |
| Apr 8, 1993 | Supplement 31Labeling | Approved | None posted |
| Nov 16, 1992 | Supplement 30Labeling | Approved | None posted |
| Oct 28, 1991 | Supplement 29Labeling | Approved | None posted |
| Mar 5, 1991 | Supplement 28Labeling | Approved | None posted |
| Aug 6, 1990 | Supplement 25Labeling | Approved | None posted |
| Mar 28, 1990 | Supplement 19Manufacturing | Approved | None posted |
| Mar 1, 1990 | Supplement 24Labeling | Approved | None posted |
| Jan 22, 1990 | Supplement 18Manufacturing | Approved | None posted |
| Jan 22, 1990 | Supplement 22Manufacturing | Approved | None posted |
| Nov 21, 1989 | Supplement 23Labeling | Approved | None posted |
| Mar 2, 1989 | Supplement 21Labeling | Approved | None posted |
| Feb 7, 1989 | Supplement 20Labeling | Approved | None posted |
| Apr 21, 1988 | Supplement 16Labeling | Approved | None posted |
| Sep 15, 1987 | Supplement 15Manufacturing | Approved | None posted |
| Sep 8, 1987 | Supplement 12Manufacturing | Approved | None posted |
| Jan 30, 1986 | Supplement 9Manufacturing | Approved | None posted |
| Dec 3, 1985 | Supplement 7Manufacturing | Approved | None posted |
| Jun 14, 1984 | Supplement 2Manufacturing | Approved | None posted |
| Jun 14, 1984 | Supplement 3Manufacturing | Approved | None posted |
| Dec 27, 1982 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters